New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.

Real-world data demonstrate that the MiniMed 780G system effectively controls glucose levels in users who do not administer ...

Six Indiana counties operate a syringe service program, often acting as a bridge to healthcare, overdose prevention education and addiction treatment. But the programs could end in July, when the law ...

Frequent urination can be an early warning sign of type 1 diabetes, which if left untreated can lead to life-threatening ...

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

Managing type 1 diabetes during cold weather requires extra attention to how you store insulin, use your devices, and manage ...

Australians are buying an unapproved weight-loss drug from suppliers whose websites list the product as “for research use ...

Joe Grantham is a contributor from the UK with a degree in Classical Studies. His love for gaming is only rivaled by a deep passion for medieval history, which often seeps into his articles. With over ...

Add Yahoo as a preferred source to see more of our stories on Google. Medtronic said Monday it received 510(k) clearance from the Food and Drug Administration for an app to connect its smart insulin ...

In this free webinar, learn how recombinant insulin improves viral production across diverse vaccine platforms. Attendees will gain insight into the role of recombinant trypsin in efficient cell ...

Cannabis products have changed a lot over the years. What was once limited to flower and a few basic edibles has expanded into oils, concentrates, capsules, and more. One product that continues to ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing research has found.